{"nct_id":"NCT03138499","title":"A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,","status":"TERMINATED","status_verified_date":"2024-01","start_date":"2017-06-26","start_date_type":"ACTUAL","primary_completion_date":"2021-02-22","primary_completion_date_type":"ACTUAL","completion_date":"2021-02-22","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BMY"]}